Transarterial chemoembolization combined with tyrosine kinase inhibitors and/or immune checkpoint inhibitors induced hypothyroidism is associated with improved overall survival in hepatocellular carcinoma

Abstract Hepatocellular carcinoma (HCC) treatments, including transarterial chemoembolization (TACE) and systemic therapies (tyrosine kinase inhibitors [TKIs]/immune checkpoint inhibitors [ICIs]) are linked to hypothyroidism. This study aims to elucidate the clinical significance of treatment-induce...

Cijeli opis

Bibliografski detalji

Glavni autori:	Shengyuan Xu, Ruipeng Zheng, Chenghao Sun, Ri Sa
Format:	Artigo
Jezik:	Inglês
Izdano:	Springer 2025-05-01
Serija:	Cancer Immunology, Immunotherapy
Teme:	Hypothyroidism Hepatocellular carcinoma Transarterial chemoembolization Tyrosine kinase inhibitors Immune checkpoint inhibitors
Online pristup:	https://doi.org/10.1007/s00262-025-04073-5
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!